SHIFT AI Newsroom · GLOBAL
GLP-1 Receptor Agonists Post-Bariatric Surgery Trial Underway
Researchers are investigating the use of GLP-1 receptor agonists after bariatric surgery, with a new trial publishing its rationale, design, and baseline characteristics.
The GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Trial has published its rationale, design, and baseline characteristics. The trial aims to investigate the effects of GLP-1 receptor agonists in patients who have undergone bariatric surgery.
What this means in the UK
The trial's findings could have implications for the management of patients in the UK who have undergone bariatric surgery, potentially informing future treatment guidelines and improving patient outcomes.
Known facts
- The GRABS trial aims to investigate the use of GLP-1 receptor agonists post-bariatric surgery.